⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PALI News
Palisade Bio, Inc. Common Stock
Form 8-K
sec.gov
PALI
Palisade Bio Welcomes Biopharmaceutical Industry Veterans Robert Baltera and Jordan Zwick to its Board of Directors
globenewswire.com
PALI
Palisade Bio to Present on the Potential of PALI-2108 for Fibrostenotic Crohn’s Disease at New York Academy of Sciences Symposium
globenewswire.com
PALI
Palisade Bio to Participate in the Jefferies Global Healthcare Conference
globenewswire.com
PALI
Palisade Bio Reports First Quarter 2026 Financial Results and Highlights Continued Clinical Progress of PALI-2108
globenewswire.com
PALI
Form 8-K
sec.gov
PALI
Palisade Bio Reports Additional Phase 1a/b Data Demonstrating Colon-Targeted Exposure and Sustained IC90 Coverage Supporting Once-Daily Dosing in Ulcerative Colitis
globenewswire.com
PALI
Palisade Bio Announces Abstract Selected for Poster Presentation at Digestive Disease Week (DDW) 2026
globenewswire.com
PALI
Palisade Bio to Present at the Needham & Co. 25th Annual Healthcare Conference
globenewswire.com
PALI
Form 8-K
sec.gov
PALI